前列腺癌的免疫基因治疗研究进展
出处
《中国免疫学杂志》
CAS
CSCD
北大核心
2005年第8期637-640,共4页
Chinese Journal of Immunology
基金
国家863计划课题(2004AA217032)
参考文献21
-
1Terasawa H,Tsang K Y, Gulley J et al. Identification and characterization of a human agonist cytotoxic T-lymphocyte epitope of human prostate-specific antigen [J] .Clin Cancer Res,2002;8:41-45.
-
2Maher J, Brentjens R J, Gunset G et al. Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta/CD28 receptor[J]. Nat Biotechnol, 2002 ;20( 1 ) :70-75.
-
3Nelson W N,Simons J W,Mikhak B et al.Cancer cells engineered to secrete granulocyte-maccrophage colony-stimulating factor using ex vivo gene transt'er as vaccines for the treatment of genitourinary maligenancies [J].Cancer Chemother Pharmacol, 2000; 46 ( 1 ) : 367-372.
-
4Mincheff M, Altankova I, Zoubak S et al. In vivo tranffection and/or cross-priming of dendritic cells following DNA and adenoviral immuniza-tions for immunotheraphy of cancea- changes in peripheral mononuclear subsets and intracellular IL-4 and IFN-gamma lymphokine profile [J].Crit Rev Oncol Hematol,2001 ;39(1-2) : 125-132.
-
5Hull G W, McCurdy M A, Nasu Y et al. Prostate cancer gene therapy:comparison of adenvirus-mediated expression of interteukin-12 with interleukin-12 plus B7-1 for in situ gone therapy and gene modified,cell-based vaccines [J] .Clin Cancer Res,2000;6:4101-4109.
-
6Griffith T S, Kawakita M,Tian J et al. Inhibition of routine prostate tumor growth and activation of immunoregulatory cells with recombinant canmypox vimses [J].J Nail Cancer Int,2001 ;92(13):998-1007.
-
7Westermann J, Aicher A, Qin Z et al. Retroviral interleukin-7 gene transfer into human dendritic cells enhances T cell activation [J]. Gene Ther,1998 ;5 ( 1 ) :264-271.
-
8Ashley D M. Bone marrow-genarated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors [J].J Exp Med, 1997; 186:1177-1182.
-
9Bcczkowski D, Nair K, Snyder D et al. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo [J] .J Exp Med,1996; 184:465-472.
-
10Heiser A, Coleman D, Dannull J et al. Autologous dendritic cells trans-fected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors [J].J Clin Invest,2002; 109:409-417.
-
1刘民培.癌症免疫基因治疗策略的研究进展[J].中国肿瘤临床与康复,1998,5(6):91-92. 被引量：1
-
2胡国信.肝癌基因治疗研究进展[J].江西医药,2002,37(1):73-75.
-
3赵亮,肖红,冯芳.神经胶质瘤基因治疗的研究进展[J].医学综述,2007,13(7):492-494. 被引量：3
-
4流小舟,吴苏稼.骨肉瘤免疫基因治疗研究进展[J].医学研究生学报,2012,25(1):95-98. 被引量：5
-
5刘军,刘兰忠.头颈部肿瘤的基因治疗[J].中华今日医学杂志,2003,3(8):92-94.
-
6李秀山.胃癌患者外科治疗的研究进展[J].医学理论与实践,2017,30(4):492-493.
-
7周方为.免疫疗法在肿瘤治疗中的地位[J].长春中医学院学报,1990,6(4):4-4.
-
8孙凤岭,臧桐,杨学辉.干扰素-α在表浅膀胱癌治疗中的应用[J].国外医学（泌尿系统分册）,2000,20(4):160-162.
-
9王雪峰,刘晓谦,杨富明.胶质瘤联合基因治疗研究进展[J].肿瘤防治研究,2003,30(2):163-164.
-
10黄东胜,严盛.胰腺癌的肿瘤标志物和免疫基因治疗研究进展[J].临床外科杂志,2005,13(4):253-255.
